It was demonstrated that SCF Vivo-Morpholino treatment (to reduce SCF expression) significantly decreased biliary senescence, as well as DR and liver fibrosis in Mdr2−/− mice (Meadows et al., 2019). This evidence concerns the gene KITLG and Hepatic fibrosis.